Risk factors associated with onset of medication-related osteonecrosis of the jaw in patients treated with denosumab

OBJECTIVES: While risk factors of bisphosphonate (BP) associated osteonecrosis of the jaw have been properly analyzed, studies focusing on risk factors associated with denosumab (DNO) are sparse. The purpose of this study was to identify risk factors influencing the onset of medication-related osteo...

Descripción completa

Detalles Bibliográficos
Autores principales: Wick, Alexander, Bankosegger, Philipp, Otto, Sven, Hohlweg-Majert, Bettina, Steiner, Timm, Probst, Florian, Ristow, Oliver, Pautke, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898220/
https://www.ncbi.nlm.nih.gov/pubmed/34812959
http://dx.doi.org/10.1007/s00784-021-04261-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898220/
https://www.ncbi.nlm.nih.gov/pubmed/34812959
http://dx.doi.org/10.1007/s00784-021-04261-4

Ejemplares similares